Literature DB >> 19820950

[Acute retinal necrosis: Clinical features and therapy options].

J Hillenkamp1, B Nölle, P Rautenberg, H Fickenscher, J Roider.   

Abstract

Varicella zoster virus is the most frequent cause of acute retinal necrosis (ARN) followed by herpes simplex virus. Retinal ischemia and optic nerve atrophy are the main causes of the frequently poor final visual outcome in severe cases of ARN. The clinical diagnosis of ARN should be made as early as possible. Acyclovir should be administered intravenously due to its unreliable oral bioavailability. Systemic corticosteroids should be applied to suppress tissue damage caused by the host's inflammatory response. Severe cases of ARN should be treated by early vitrectomy with diagnostic vitreous biopsy, intravitreal aciclovir lavage, intraoperative laser retinopexy and silicone oil tamponade. The role of prophylactic laser retinopexy for prevention of secondary retinal detachment remains to be determined. The cause of different degrees of severity of ARN is unknown. The degree of severity of ARN is probably an independent predictor of the functional outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19820950     DOI: 10.1007/s00347-009-2047-5

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  30 in total

1.  Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society.

Authors:  G N Holland
Journal:  Am J Ophthalmol       Date:  1994-05-15       Impact factor: 5.258

2.  Bilateral acute retinal necrosis.

Authors:  N J Young; A C Bird
Journal:  Br J Ophthalmol       Date:  1978-09       Impact factor: 4.638

3.  Acute retinal necrosis features, management, and outcomes.

Authors:  Chun H Lau; Tom Missotten; Joel Salzmann; Susan L Lightman
Journal:  Ophthalmology       Date:  2006-12-20       Impact factor: 12.079

4.  [Acute retinal necrosis syndrome. Argon laser coagulation for prevention of rhegmatogenic retinal detachment].

Authors:  T Hudde; C Althaus; R Sundmacher
Journal:  Ophthalmologe       Date:  1998-07       Impact factor: 1.059

5.  An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4.

Authors:  G N Holland; P J Cornell; M S Park; A Barbetti; J Yuge; A E Kreiger; H J Kaplan; J S Pepose; J R Heckenlively; W W Culbertson
Journal:  Am J Ophthalmol       Date:  1989-10-15       Impact factor: 5.258

6.  Neuronal pathways for the propagation of herpes simplex virus type 1 from one retina to the other in a murine model.

Authors:  M Labetoulle; P Kucera; G Ugolini; F Lafay; E Frau; H Offret; A Flamand
Journal:  J Gen Virol       Date:  2000-05       Impact factor: 3.891

7.  The acute retinal necrosis syndrome. Part 2: Histopathology and etiology.

Authors:  W W Culbertson; M S Blumenkranz; H Haines; D M Gass; K B Mitchell; E W Norton
Journal:  Ophthalmology       Date:  1982-12       Impact factor: 12.079

8.  Laser photocoagulation in the acute retinal necrosis syndrome.

Authors:  D P Han; H Lewis; G A Williams; W F Mieler; G W Abrams; T M Aaberg
Journal:  Arch Ophthalmol       Date:  1987-08

9.  Surgical management of retinal detachment associated with the acute retinal necrosis syndrome.

Authors:  H R McDonald; H Lewis; A E Kreiger; Y Sidikaro; J Heckenlively
Journal:  Br J Ophthalmol       Date:  1991-08       Impact factor: 4.638

10.  Platelet function in bilateral acute retinal necrosis.

Authors:  F Ando; M Kato; S Goto; K Kobayashi; H Ichikawa; T Kamiya
Journal:  Am J Ophthalmol       Date:  1983-07       Impact factor: 5.258

View more
  2 in total

1.  The Role of Plasmacytoid Dendritic Cells in Innate and Adaptive Immune Responses against Alpha Herpes Virus Infections.

Authors:  Philipp Schuster; Jan Bernardin Boscheinen; Karin Tennert; Barbara Schmidt
Journal:  Adv Virol       Date:  2011-03-31

2.  Identification of an indol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor.

Authors:  Simona Musella; Veronica di Sarno; Tania Ciaglia; Marina Sala; Antonia Spensiero; Maria Carmina Scala; Carmine Ostacolo; Graciela Andrei; Jan Balzarini; Robert Snoeck; Ettore Novellino; Pietro Campiglia; Alessia Bertamino; Isabel M Gomez-Monterrey
Journal:  Eur J Med Chem       Date:  2016-09-07       Impact factor: 6.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.